Hjem › Metastatisk kreft › South Carolina › Myrtle Beach
Kliniske studier for Metastatisk kreft i Myrtle Beach, SC
5 studier for Metastatisk kreft søker deltakere på steder i og rundt Myrtle Beach (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)
RekruttererFase 1/2
- Avenzo Therapeutics Recruiting Site, Myrtle Beach
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
RekruttererFase 1/2
- Grand Strand Medical Center, Myrtle Beach
- Carolina Urologic Research Center, LLC, Myrtle Beach
- Parkway Surgery Center, Myrtle Beach
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
RekruttererFase 1
- Carolina Urologic Research Center, Myrtle Beach
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
RekruttererFase 1
- Carolina Urologic Research Center, the START Center for Cancer Research, Myrtle Beach
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
RekruttererFase 1
- Carolina Urologic Research Center, Myrtle Beach
Metastatisk kreft-studier i andre byer
- Houston, TX104 studier
- New York City, NY93 studier
- Nashville, TN70 studier
- Boston, MA63 studier
- Los Angeles, CA57 studier
- St. Louis, MO54 studier
- Arlington, VA53 studier
- Philadelphia, PA46 studier
- Chicago, IL45 studier
- San Antonio, TX44 studier
- Washington, DC43 studier
- Dallas, TX42 studier
Andre studier i Myrtle Beach
- Prostatakreft24 studier
- Blærekreft10 studier
- Ikke-muskulinvasiv blærecancer9 studier
- Nyrekreft (nyrecellekarcinom)6 studier
- Urotelial (overgangscelle) karcinom5 studier
- Type 2-diabetes3 studier
- Kastrasjonsresistent prostatakreft3 studier
- Kreft (alle typer)3 studier
- Carcinom in situ3 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.